nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—SCN10A—breast cancer	0.245	0.67	CbGaD
Rufinamide—CES1—Capecitabine—breast cancer	0.0833	0.226	CbGbCtD
Rufinamide—CES1—Tamoxifen—breast cancer	0.067	0.182	CbGbCtD
Rufinamide—CYP3A4—breast cancer	0.0644	0.176	CbGaD
Rufinamide—ALB—breast cancer	0.0562	0.154	CbGaD
Rufinamide—CES1—Irinotecan—breast cancer	0.0515	0.139	CbGbCtD
Rufinamide—CYP3A4—Exemestane—breast cancer	0.0156	0.0423	CbGbCtD
Rufinamide—CYP3A4—Letrozole—breast cancer	0.0133	0.036	CbGbCtD
Rufinamide—CYP2E1—Tamoxifen—breast cancer	0.0131	0.0353	CbGbCtD
Rufinamide—CYP2E1—Mitoxantrone—breast cancer	0.0127	0.0345	CbGbCtD
Rufinamide—CYP3A4—Anastrozole—breast cancer	0.0118	0.0321	CbGbCtD
Rufinamide—CYP3A4—Toremifene—breast cancer	0.0108	0.0293	CbGbCtD
Rufinamide—CYP3A4—Fulvestrant—breast cancer	0.0101	0.0273	CbGbCtD
Rufinamide—ALB—Irinotecan—breast cancer	0.00969	0.0262	CbGbCtD
Rufinamide—ALB—Fluorouracil—breast cancer	0.0093	0.0252	CbGbCtD
Rufinamide—CYP3A4—Thiotepa—breast cancer	0.00897	0.0243	CbGbCtD
Rufinamide—CYP3A4—Ixabepilone—breast cancer	0.00821	0.0222	CbGbCtD
Rufinamide—CYP3A4—Lapatinib—breast cancer	0.0079	0.0214	CbGbCtD
Rufinamide—CYP3A4—Raloxifene—breast cancer	0.00599	0.0162	CbGbCtD
Rufinamide—ALB—Methotrexate—breast cancer	0.00513	0.0139	CbGbCtD
Rufinamide—CYP3A4—Vinorelbine—breast cancer	0.00438	0.0119	CbGbCtD
Rufinamide—CYP3A4—Tamoxifen—breast cancer	0.00395	0.0107	CbGbCtD
Rufinamide—CYP3A4—Mitoxantrone—breast cancer	0.00386	0.0104	CbGbCtD
Rufinamide—CYP3A4—Paclitaxel—breast cancer	0.00308	0.00834	CbGbCtD
Rufinamide—CYP3A4—Irinotecan—breast cancer	0.00304	0.00822	CbGbCtD
Rufinamide—CYP3A4—Vinblastine—breast cancer	0.0027	0.00731	CbGbCtD
Rufinamide—CYP3A4—Docetaxel—breast cancer	0.00223	0.00603	CbGbCtD
Rufinamide—CYP3A4—Doxorubicin—breast cancer	0.00166	0.00449	CbGbCtD
Rufinamide—GRM5—female reproductive system—breast cancer	0.00121	0.0604	CbGeAlD
Rufinamide—GRM5—endocrine gland—breast cancer	0.00102	0.0511	CbGeAlD
Rufinamide—SCN7A—adipose tissue—breast cancer	0.000829	0.0415	CbGeAlD
Rufinamide—ALB—mammary gland—breast cancer	0.000799	0.04	CbGeAlD
Rufinamide—SCN7A—female reproductive system—breast cancer	0.000762	0.0381	CbGeAlD
Rufinamide—SCN7A—adrenal gland—breast cancer	0.000744	0.0372	CbGeAlD
Rufinamide—SCN7A—female gonad—breast cancer	0.000693	0.0347	CbGeAlD
Rufinamide—SCN9A—pituitary gland—breast cancer	0.000652	0.0326	CbGeAlD
Rufinamide—SCN9A—adipose tissue—breast cancer	0.000649	0.0325	CbGeAlD
Rufinamide—SCN7A—endocrine gland—breast cancer	0.000645	0.0323	CbGeAlD
Rufinamide—SCN9A—adrenal gland—breast cancer	0.000583	0.0292	CbGeAlD
Rufinamide—SCN4A—pituitary gland—breast cancer	0.000582	0.0291	CbGeAlD
Rufinamide—SCN4A—adipose tissue—breast cancer	0.000579	0.029	CbGeAlD
Rufinamide—SCN8A—endocrine gland—breast cancer	0.000575	0.0288	CbGeAlD
Rufinamide—SCN4A—adrenal gland—breast cancer	0.00052	0.026	CbGeAlD
Rufinamide—CES1—adipose tissue—breast cancer	0.000517	0.0259	CbGeAlD
Rufinamide—SCN2A—pituitary gland—breast cancer	0.000515	0.0258	CbGeAlD
Rufinamide—SCN10A—pituitary gland—breast cancer	0.000496	0.0249	CbGeAlD
Rufinamide—CES1—female reproductive system—breast cancer	0.000476	0.0238	CbGeAlD
Rufinamide—CES1—adrenal gland—breast cancer	0.000464	0.0232	CbGeAlD
Rufinamide—SCN3A—pituitary gland—breast cancer	0.000452	0.0226	CbGeAlD
Rufinamide—SCN3A—adipose tissue—breast cancer	0.000451	0.0226	CbGeAlD
Rufinamide—SCN7A—lymph node—breast cancer	0.000446	0.0223	CbGeAlD
Rufinamide—CES1—female gonad—breast cancer	0.000433	0.0217	CbGeAlD
Rufinamide—SCN3A—female reproductive system—breast cancer	0.000414	0.0207	CbGeAlD
Rufinamide—SCN3A—adrenal gland—breast cancer	0.000404	0.0202	CbGeAlD
Rufinamide—CES1—endocrine gland—breast cancer	0.000403	0.0201	CbGeAlD
Rufinamide—SCN2A—endocrine gland—breast cancer	0.000399	0.02	CbGeAlD
Rufinamide—SCN3A—bone marrow—breast cancer	0.000391	0.0196	CbGeAlD
Rufinamide—SCN10A—endocrine gland—breast cancer	0.000385	0.0193	CbGeAlD
Rufinamide—SCN9A—lymph node—breast cancer	0.000349	0.0175	CbGeAlD
Rufinamide—ALB—adrenal gland—breast cancer	0.000323	0.0162	CbGeAlD
Rufinamide—CES1—lymph node—breast cancer	0.000278	0.0139	CbGeAlD
Rufinamide—SCN10A—lymph node—breast cancer	0.000266	0.0133	CbGeAlD
Rufinamide—SCN3A—lymph node—breast cancer	0.000242	0.0121	CbGeAlD
Rufinamide—CYP2E1—female reproductive system—breast cancer	0.000196	0.00979	CbGeAlD
Rufinamide—ALB—lymph node—breast cancer	0.000193	0.00968	CbGeAlD
Rufinamide—CYP2E1—adrenal gland—breast cancer	0.000191	0.00955	CbGeAlD
Rufinamide—CYP2E1—endocrine gland—breast cancer	0.000166	0.00829	CbGeAlD
Rufinamide—CYP3A4—female reproductive system—breast cancer	0.000157	0.00788	CbGeAlD
Rufinamide—CYP3A4—endocrine gland—breast cancer	0.000133	0.00667	CbGeAlD
Rufinamide—Headache—Vinorelbine—breast cancer	6.73e-05	0.00048	CcSEcCtD
Rufinamide—Influenza—Doxorubicin—breast cancer	6.72e-05	0.00048	CcSEcCtD
Rufinamide—Leukopenia—Docetaxel—breast cancer	6.71e-05	0.000479	CcSEcCtD
Rufinamide—Anaemia—Capecitabine—breast cancer	6.71e-05	0.000479	CcSEcCtD
Rufinamide—Pollakiuria—Epirubicin—breast cancer	6.71e-05	0.000479	CcSEcCtD
Rufinamide—Haematuria—Methotrexate—breast cancer	6.59e-05	0.000471	CcSEcCtD
Rufinamide—Weight decreased—Epirubicin—breast cancer	6.57e-05	0.000469	CcSEcCtD
Rufinamide—Hepatobiliary disease—Methotrexate—breast cancer	6.54e-05	0.000467	CcSEcCtD
Rufinamide—Insomnia—Paclitaxel—breast cancer	6.53e-05	0.000466	CcSEcCtD
Rufinamide—Epistaxis—Methotrexate—breast cancer	6.52e-05	0.000466	CcSEcCtD
Rufinamide—Vertigo—Capecitabine—breast cancer	6.52e-05	0.000466	CcSEcCtD
Rufinamide—Hypersensitivity—Mitoxantrone—breast cancer	6.52e-05	0.000466	CcSEcCtD
Rufinamide—Hypersensitivity—Irinotecan—breast cancer	6.52e-05	0.000466	CcSEcCtD
Rufinamide—Vomiting—Thiotepa—breast cancer	6.52e-05	0.000465	CcSEcCtD
Rufinamide—Pneumonia—Epirubicin—breast cancer	6.51e-05	0.000465	CcSEcCtD
Rufinamide—Leukopenia—Capecitabine—breast cancer	6.5e-05	0.000464	CcSEcCtD
Rufinamide—Convulsion—Docetaxel—breast cancer	6.5e-05	0.000464	CcSEcCtD
Rufinamide—Infestation NOS—Epirubicin—breast cancer	6.47e-05	0.000462	CcSEcCtD
Rufinamide—Infestation—Epirubicin—breast cancer	6.47e-05	0.000462	CcSEcCtD
Rufinamide—Rash—Thiotepa—breast cancer	6.46e-05	0.000462	CcSEcCtD
Rufinamide—Bronchitis—Doxorubicin—breast cancer	6.46e-05	0.000461	CcSEcCtD
Rufinamide—Dermatitis—Thiotepa—breast cancer	6.46e-05	0.000461	CcSEcCtD
Rufinamide—Headache—Thiotepa—breast cancer	6.42e-05	0.000459	CcSEcCtD
Rufinamide—Somnolence—Paclitaxel—breast cancer	6.42e-05	0.000458	CcSEcCtD
Rufinamide—Nausea—Vinorelbine—breast cancer	6.38e-05	0.000455	CcSEcCtD
Rufinamide—Dyspepsia—Paclitaxel—breast cancer	6.36e-05	0.000454	CcSEcCtD
Rufinamide—Asthenia—Mitoxantrone—breast cancer	6.35e-05	0.000454	CcSEcCtD
Rufinamide—Asthenia—Irinotecan—breast cancer	6.35e-05	0.000454	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	6.34e-05	0.000453	CcSEcCtD
Rufinamide—Neutropenia—Doxorubicin—breast cancer	6.28e-05	0.000448	CcSEcCtD
Rufinamide—Dysuria—Doxorubicin—breast cancer	6.28e-05	0.000448	CcSEcCtD
Rufinamide—Decreased appetite—Paclitaxel—breast cancer	6.28e-05	0.000448	CcSEcCtD
Rufinamide—Hypersensitivity—Fluorouracil—breast cancer	6.25e-05	0.000446	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Paclitaxel—breast cancer	6.23e-05	0.000445	CcSEcCtD
Rufinamide—Fatigue—Paclitaxel—breast cancer	6.23e-05	0.000444	CcSEcCtD
Rufinamide—Pollakiuria—Doxorubicin—breast cancer	6.2e-05	0.000443	CcSEcCtD
Rufinamide—Asthenia—Gemcitabine—breast cancer	6.19e-05	0.000442	CcSEcCtD
Rufinamide—Constipation—Paclitaxel—breast cancer	6.17e-05	0.000441	CcSEcCtD
Rufinamide—Haematuria—Epirubicin—breast cancer	6.17e-05	0.000441	CcSEcCtD
Rufinamide—Anxiety—Capecitabine—breast cancer	6.16e-05	0.00044	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	6.14e-05	0.000438	CcSEcCtD
Rufinamide—Urinary tract disorder—Methotrexate—breast cancer	6.13e-05	0.000438	CcSEcCtD
Rufinamide—Hepatobiliary disease—Epirubicin—breast cancer	6.12e-05	0.000437	CcSEcCtD
Rufinamide—Epistaxis—Epirubicin—breast cancer	6.11e-05	0.000436	CcSEcCtD
Rufinamide—Pruritus—Gemcitabine—breast cancer	6.1e-05	0.000436	CcSEcCtD
Rufinamide—Nausea—Thiotepa—breast cancer	6.09e-05	0.000435	CcSEcCtD
Rufinamide—Urethral disorder—Methotrexate—breast cancer	6.09e-05	0.000435	CcSEcCtD
Rufinamide—Infection—Docetaxel—breast cancer	6.08e-05	0.000434	CcSEcCtD
Rufinamide—Weight decreased—Doxorubicin—breast cancer	6.08e-05	0.000434	CcSEcCtD
Rufinamide—Sinusitis—Epirubicin—breast cancer	6.07e-05	0.000434	CcSEcCtD
Rufinamide—Diarrhoea—Mitoxantrone—breast cancer	6.06e-05	0.000433	CcSEcCtD
Rufinamide—Diarrhoea—Irinotecan—breast cancer	6.06e-05	0.000433	CcSEcCtD
Rufinamide—Pneumonia—Doxorubicin—breast cancer	6.02e-05	0.00043	CcSEcCtD
Rufinamide—Nervous system disorder—Docetaxel—breast cancer	6e-05	0.000429	CcSEcCtD
Rufinamide—Pruritus—Fluorouracil—breast cancer	6e-05	0.000428	CcSEcCtD
Rufinamide—Thrombocytopenia—Docetaxel—breast cancer	5.99e-05	0.000428	CcSEcCtD
Rufinamide—Infestation NOS—Doxorubicin—breast cancer	5.99e-05	0.000428	CcSEcCtD
Rufinamide—Infestation—Doxorubicin—breast cancer	5.99e-05	0.000428	CcSEcCtD
Rufinamide—Skin disorder—Docetaxel—breast cancer	5.94e-05	0.000424	CcSEcCtD
Rufinamide—Diarrhoea—Gemcitabine—breast cancer	5.9e-05	0.000421	CcSEcCtD
Rufinamide—Infection—Capecitabine—breast cancer	5.89e-05	0.00042	CcSEcCtD
Rufinamide—Dizziness—Irinotecan—breast cancer	5.85e-05	0.000418	CcSEcCtD
Rufinamide—Anorexia—Docetaxel—breast cancer	5.83e-05	0.000417	CcSEcCtD
Rufinamide—Rhinitis—Epirubicin—breast cancer	5.83e-05	0.000416	CcSEcCtD
Rufinamide—Nervous system disorder—Capecitabine—breast cancer	5.81e-05	0.000415	CcSEcCtD
Rufinamide—Eye disorder—Methotrexate—breast cancer	5.8e-05	0.000414	CcSEcCtD
Rufinamide—Diarrhoea—Fluorouracil—breast cancer	5.8e-05	0.000414	CcSEcCtD
Rufinamide—Thrombocytopenia—Capecitabine—breast cancer	5.8e-05	0.000414	CcSEcCtD
Rufinamide—Cardiac disorder—Methotrexate—breast cancer	5.76e-05	0.000411	CcSEcCtD
Rufinamide—Skin disorder—Capecitabine—breast cancer	5.76e-05	0.000411	CcSEcCtD
Rufinamide—Urinary tract disorder—Epirubicin—breast cancer	5.74e-05	0.00041	CcSEcCtD
Rufinamide—Haematuria—Doxorubicin—breast cancer	5.71e-05	0.000408	CcSEcCtD
Rufinamide—Urethral disorder—Epirubicin—breast cancer	5.7e-05	0.000407	CcSEcCtD
Rufinamide—Hepatobiliary disease—Doxorubicin—breast cancer	5.66e-05	0.000404	CcSEcCtD
Rufinamide—Epistaxis—Doxorubicin—breast cancer	5.65e-05	0.000403	CcSEcCtD
Rufinamide—Anorexia—Capecitabine—breast cancer	5.65e-05	0.000403	CcSEcCtD
Rufinamide—Vomiting—Mitoxantrone—breast cancer	5.63e-05	0.000402	CcSEcCtD
Rufinamide—Vomiting—Irinotecan—breast cancer	5.63e-05	0.000402	CcSEcCtD
Rufinamide—Sinusitis—Doxorubicin—breast cancer	5.62e-05	0.000401	CcSEcCtD
Rufinamide—Immune system disorder—Methotrexate—breast cancer	5.61e-05	0.0004	CcSEcCtD
Rufinamide—Dizziness—Fluorouracil—breast cancer	5.61e-05	0.0004	CcSEcCtD
Rufinamide—Mediastinal disorder—Methotrexate—breast cancer	5.6e-05	0.0004	CcSEcCtD
Rufinamide—Rash—Mitoxantrone—breast cancer	5.58e-05	0.000399	CcSEcCtD
Rufinamide—Rash—Irinotecan—breast cancer	5.58e-05	0.000399	CcSEcCtD
Rufinamide—Dermatitis—Mitoxantrone—breast cancer	5.58e-05	0.000398	CcSEcCtD
Rufinamide—Dermatitis—Irinotecan—breast cancer	5.58e-05	0.000398	CcSEcCtD
Rufinamide—Headache—Mitoxantrone—breast cancer	5.55e-05	0.000396	CcSEcCtD
Rufinamide—Headache—Irinotecan—breast cancer	5.55e-05	0.000396	CcSEcCtD
Rufinamide—Insomnia—Docetaxel—breast cancer	5.54e-05	0.000395	CcSEcCtD
Rufinamide—Vomiting—Gemcitabine—breast cancer	5.48e-05	0.000392	CcSEcCtD
Rufinamide—Somnolence—Docetaxel—breast cancer	5.44e-05	0.000388	CcSEcCtD
Rufinamide—Mental disorder—Methotrexate—breast cancer	5.44e-05	0.000388	CcSEcCtD
Rufinamide—Rash—Gemcitabine—breast cancer	5.44e-05	0.000388	CcSEcCtD
Rufinamide—Dermatitis—Gemcitabine—breast cancer	5.43e-05	0.000388	CcSEcCtD
Rufinamide—Eye disorder—Epirubicin—breast cancer	5.43e-05	0.000388	CcSEcCtD
Rufinamide—Malnutrition—Methotrexate—breast cancer	5.4e-05	0.000386	CcSEcCtD
Rufinamide—Headache—Gemcitabine—breast cancer	5.4e-05	0.000386	CcSEcCtD
Rufinamide—Cardiac disorder—Epirubicin—breast cancer	5.39e-05	0.000385	CcSEcCtD
Rufinamide—Vomiting—Fluorouracil—breast cancer	5.39e-05	0.000385	CcSEcCtD
Rufinamide—Rhinitis—Doxorubicin—breast cancer	5.39e-05	0.000385	CcSEcCtD
Rufinamide—Dyspepsia—Docetaxel—breast cancer	5.39e-05	0.000385	CcSEcCtD
Rufinamide—Insomnia—Capecitabine—breast cancer	5.36e-05	0.000383	CcSEcCtD
Rufinamide—Rash—Fluorouracil—breast cancer	5.35e-05	0.000382	CcSEcCtD
Rufinamide—Dermatitis—Fluorouracil—breast cancer	5.34e-05	0.000381	CcSEcCtD
Rufinamide—Decreased appetite—Docetaxel—breast cancer	5.32e-05	0.00038	CcSEcCtD
Rufinamide—Hypersensitivity—Paclitaxel—breast cancer	5.32e-05	0.00038	CcSEcCtD
Rufinamide—Headache—Fluorouracil—breast cancer	5.31e-05	0.000379	CcSEcCtD
Rufinamide—Urinary tract disorder—Doxorubicin—breast cancer	5.31e-05	0.000379	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Docetaxel—breast cancer	5.28e-05	0.000377	CcSEcCtD
Rufinamide—Fatigue—Docetaxel—breast cancer	5.28e-05	0.000377	CcSEcCtD
Rufinamide—Urethral disorder—Doxorubicin—breast cancer	5.27e-05	0.000376	CcSEcCtD
Rufinamide—Nausea—Mitoxantrone—breast cancer	5.26e-05	0.000375	CcSEcCtD
Rufinamide—Nausea—Irinotecan—breast cancer	5.26e-05	0.000375	CcSEcCtD
Rufinamide—Immune system disorder—Epirubicin—breast cancer	5.25e-05	0.000375	CcSEcCtD
Rufinamide—Mediastinal disorder—Epirubicin—breast cancer	5.24e-05	0.000374	CcSEcCtD
Rufinamide—Constipation—Docetaxel—breast cancer	5.23e-05	0.000374	CcSEcCtD
Rufinamide—Back pain—Methotrexate—breast cancer	5.23e-05	0.000373	CcSEcCtD
Rufinamide—Dyspepsia—Capecitabine—breast cancer	5.22e-05	0.000372	CcSEcCtD
Rufinamide—Asthenia—Paclitaxel—breast cancer	5.18e-05	0.00037	CcSEcCtD
Rufinamide—Decreased appetite—Capecitabine—breast cancer	5.15e-05	0.000368	CcSEcCtD
Rufinamide—Nausea—Gemcitabine—breast cancer	5.12e-05	0.000366	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Capecitabine—breast cancer	5.12e-05	0.000365	CcSEcCtD
Rufinamide—Fatigue—Capecitabine—breast cancer	5.11e-05	0.000365	CcSEcCtD
Rufinamide—Pruritus—Paclitaxel—breast cancer	5.11e-05	0.000365	CcSEcCtD
Rufinamide—Vision blurred—Methotrexate—breast cancer	5.09e-05	0.000364	CcSEcCtD
Rufinamide—Mental disorder—Epirubicin—breast cancer	5.09e-05	0.000363	CcSEcCtD
Rufinamide—Constipation—Capecitabine—breast cancer	5.07e-05	0.000362	CcSEcCtD
Rufinamide—Malnutrition—Epirubicin—breast cancer	5.06e-05	0.000361	CcSEcCtD
Rufinamide—Nausea—Fluorouracil—breast cancer	5.04e-05	0.00036	CcSEcCtD
Rufinamide—Eye disorder—Doxorubicin—breast cancer	5.02e-05	0.000359	CcSEcCtD
Rufinamide—Anaemia—Methotrexate—breast cancer	5e-05	0.000357	CcSEcCtD
Rufinamide—Cardiac disorder—Doxorubicin—breast cancer	4.99e-05	0.000356	CcSEcCtD
Rufinamide—Diarrhoea—Paclitaxel—breast cancer	4.94e-05	0.000353	CcSEcCtD
Rufinamide—Back pain—Epirubicin—breast cancer	4.89e-05	0.000349	CcSEcCtD
Rufinamide—Immune system disorder—Doxorubicin—breast cancer	4.86e-05	0.000347	CcSEcCtD
Rufinamide—Vertigo—Methotrexate—breast cancer	4.86e-05	0.000347	CcSEcCtD
Rufinamide—Mediastinal disorder—Doxorubicin—breast cancer	4.85e-05	0.000346	CcSEcCtD
Rufinamide—Leukopenia—Methotrexate—breast cancer	4.84e-05	0.000345	CcSEcCtD
Rufinamide—Dizziness—Paclitaxel—breast cancer	4.77e-05	0.000341	CcSEcCtD
Rufinamide—Vision blurred—Epirubicin—breast cancer	4.77e-05	0.00034	CcSEcCtD
Rufinamide—Mental disorder—Doxorubicin—breast cancer	4.71e-05	0.000336	CcSEcCtD
Rufinamide—Convulsion—Methotrexate—breast cancer	4.68e-05	0.000334	CcSEcCtD
Rufinamide—Malnutrition—Doxorubicin—breast cancer	4.68e-05	0.000334	CcSEcCtD
Rufinamide—Anaemia—Epirubicin—breast cancer	4.68e-05	0.000334	CcSEcCtD
Rufinamide—Agitation—Epirubicin—breast cancer	4.65e-05	0.000332	CcSEcCtD
Rufinamide—Vomiting—Paclitaxel—breast cancer	4.59e-05	0.000328	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	4.57e-05	0.000326	CcSEcCtD
Rufinamide—Rash—Paclitaxel—breast cancer	4.55e-05	0.000325	CcSEcCtD
Rufinamide—Dermatitis—Paclitaxel—breast cancer	4.55e-05	0.000325	CcSEcCtD
Rufinamide—Vertigo—Epirubicin—breast cancer	4.54e-05	0.000324	CcSEcCtD
Rufinamide—Leukopenia—Epirubicin—breast cancer	4.53e-05	0.000323	CcSEcCtD
Rufinamide—Back pain—Doxorubicin—breast cancer	4.53e-05	0.000323	CcSEcCtD
Rufinamide—Headache—Paclitaxel—breast cancer	4.52e-05	0.000323	CcSEcCtD
Rufinamide—Hypersensitivity—Docetaxel—breast cancer	4.51e-05	0.000322	CcSEcCtD
Rufinamide—Vision blurred—Doxorubicin—breast cancer	4.41e-05	0.000315	CcSEcCtD
Rufinamide—Asthenia—Docetaxel—breast cancer	4.39e-05	0.000314	CcSEcCtD
Rufinamide—Convulsion—Epirubicin—breast cancer	4.38e-05	0.000313	CcSEcCtD
Rufinamide—Infection—Methotrexate—breast cancer	4.38e-05	0.000313	CcSEcCtD
Rufinamide—Hypersensitivity—Capecitabine—breast cancer	4.37e-05	0.000312	CcSEcCtD
Rufinamide—Pruritus—Docetaxel—breast cancer	4.33e-05	0.000309	CcSEcCtD
Rufinamide—Nervous system disorder—Methotrexate—breast cancer	4.33e-05	0.000309	CcSEcCtD
Rufinamide—Anaemia—Doxorubicin—breast cancer	4.33e-05	0.000309	CcSEcCtD
Rufinamide—Thrombocytopenia—Methotrexate—breast cancer	4.32e-05	0.000308	CcSEcCtD
Rufinamide—Agitation—Doxorubicin—breast cancer	4.3e-05	0.000307	CcSEcCtD
Rufinamide—Anxiety—Epirubicin—breast cancer	4.29e-05	0.000306	CcSEcCtD
Rufinamide—Nausea—Paclitaxel—breast cancer	4.29e-05	0.000306	CcSEcCtD
Rufinamide—Skin disorder—Methotrexate—breast cancer	4.28e-05	0.000306	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.28e-05	0.000305	CcSEcCtD
Rufinamide—Asthenia—Capecitabine—breast cancer	4.25e-05	0.000304	CcSEcCtD
Rufinamide—Vertigo—Doxorubicin—breast cancer	4.2e-05	0.0003	CcSEcCtD
Rufinamide—Anorexia—Methotrexate—breast cancer	4.2e-05	0.0003	CcSEcCtD
Rufinamide—Pruritus—Capecitabine—breast cancer	4.19e-05	0.000299	CcSEcCtD
Rufinamide—Leukopenia—Doxorubicin—breast cancer	4.19e-05	0.000299	CcSEcCtD
Rufinamide—Diarrhoea—Docetaxel—breast cancer	4.19e-05	0.000299	CcSEcCtD
Rufinamide—Infection—Epirubicin—breast cancer	4.1e-05	0.000293	CcSEcCtD
Rufinamide—Convulsion—Doxorubicin—breast cancer	4.06e-05	0.00029	CcSEcCtD
Rufinamide—Diarrhoea—Capecitabine—breast cancer	4.05e-05	0.000289	CcSEcCtD
Rufinamide—Nervous system disorder—Epirubicin—breast cancer	4.05e-05	0.000289	CcSEcCtD
Rufinamide—Dizziness—Docetaxel—breast cancer	4.05e-05	0.000289	CcSEcCtD
Rufinamide—Thrombocytopenia—Epirubicin—breast cancer	4.04e-05	0.000289	CcSEcCtD
Rufinamide—Skin disorder—Epirubicin—breast cancer	4.01e-05	0.000286	CcSEcCtD
Rufinamide—Insomnia—Methotrexate—breast cancer	3.99e-05	0.000285	CcSEcCtD
Rufinamide—Anxiety—Doxorubicin—breast cancer	3.97e-05	0.000283	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.96e-05	0.000283	CcSEcCtD
Rufinamide—Anorexia—Epirubicin—breast cancer	3.94e-05	0.000281	CcSEcCtD
Rufinamide—Somnolence—Methotrexate—breast cancer	3.92e-05	0.00028	CcSEcCtD
Rufinamide—Dizziness—Capecitabine—breast cancer	3.92e-05	0.00028	CcSEcCtD
Rufinamide—Vomiting—Docetaxel—breast cancer	3.89e-05	0.000278	CcSEcCtD
Rufinamide—Dyspepsia—Methotrexate—breast cancer	3.88e-05	0.000277	CcSEcCtD
Rufinamide—Rash—Docetaxel—breast cancer	3.86e-05	0.000276	CcSEcCtD
Rufinamide—Dermatitis—Docetaxel—breast cancer	3.86e-05	0.000275	CcSEcCtD
Rufinamide—Decreased appetite—Methotrexate—breast cancer	3.83e-05	0.000274	CcSEcCtD
Rufinamide—Headache—Docetaxel—breast cancer	3.83e-05	0.000274	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Methotrexate—breast cancer	3.81e-05	0.000272	CcSEcCtD
Rufinamide—Fatigue—Methotrexate—breast cancer	3.8e-05	0.000272	CcSEcCtD
Rufinamide—Infection—Doxorubicin—breast cancer	3.79e-05	0.000271	CcSEcCtD
Rufinamide—Vomiting—Capecitabine—breast cancer	3.77e-05	0.000269	CcSEcCtD
Rufinamide—Nervous system disorder—Doxorubicin—breast cancer	3.75e-05	0.000267	CcSEcCtD
Rufinamide—Thrombocytopenia—Doxorubicin—breast cancer	3.74e-05	0.000267	CcSEcCtD
Rufinamide—Rash—Capecitabine—breast cancer	3.74e-05	0.000267	CcSEcCtD
Rufinamide—Insomnia—Epirubicin—breast cancer	3.73e-05	0.000267	CcSEcCtD
Rufinamide—Dermatitis—Capecitabine—breast cancer	3.73e-05	0.000267	CcSEcCtD
Rufinamide—Headache—Capecitabine—breast cancer	3.71e-05	0.000265	CcSEcCtD
Rufinamide—Skin disorder—Doxorubicin—breast cancer	3.71e-05	0.000265	CcSEcCtD
Rufinamide—Somnolence—Epirubicin—breast cancer	3.67e-05	0.000262	CcSEcCtD
Rufinamide—Anorexia—Doxorubicin—breast cancer	3.64e-05	0.00026	CcSEcCtD
Rufinamide—Nausea—Docetaxel—breast cancer	3.64e-05	0.00026	CcSEcCtD
Rufinamide—Dyspepsia—Epirubicin—breast cancer	3.63e-05	0.000259	CcSEcCtD
Rufinamide—Decreased appetite—Epirubicin—breast cancer	3.59e-05	0.000256	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Epirubicin—breast cancer	3.56e-05	0.000254	CcSEcCtD
Rufinamide—Fatigue—Epirubicin—breast cancer	3.56e-05	0.000254	CcSEcCtD
Rufinamide—Constipation—Epirubicin—breast cancer	3.53e-05	0.000252	CcSEcCtD
Rufinamide—Nausea—Capecitabine—breast cancer	3.52e-05	0.000251	CcSEcCtD
Rufinamide—Insomnia—Doxorubicin—breast cancer	3.45e-05	0.000247	CcSEcCtD
Rufinamide—Somnolence—Doxorubicin—breast cancer	3.4e-05	0.000242	CcSEcCtD
Rufinamide—Dyspepsia—Doxorubicin—breast cancer	3.36e-05	0.00024	CcSEcCtD
Rufinamide—Decreased appetite—Doxorubicin—breast cancer	3.32e-05	0.000237	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Doxorubicin—breast cancer	3.3e-05	0.000235	CcSEcCtD
Rufinamide—Fatigue—Doxorubicin—breast cancer	3.29e-05	0.000235	CcSEcCtD
Rufinamide—Constipation—Doxorubicin—breast cancer	3.27e-05	0.000233	CcSEcCtD
Rufinamide—Hypersensitivity—Methotrexate—breast cancer	3.25e-05	0.000232	CcSEcCtD
Rufinamide—Asthenia—Methotrexate—breast cancer	3.16e-05	0.000226	CcSEcCtD
Rufinamide—Pruritus—Methotrexate—breast cancer	3.12e-05	0.000223	CcSEcCtD
Rufinamide—Hypersensitivity—Epirubicin—breast cancer	3.04e-05	0.000217	CcSEcCtD
Rufinamide—Diarrhoea—Methotrexate—breast cancer	3.02e-05	0.000215	CcSEcCtD
Rufinamide—Asthenia—Epirubicin—breast cancer	2.96e-05	0.000211	CcSEcCtD
Rufinamide—Pruritus—Epirubicin—breast cancer	2.92e-05	0.000209	CcSEcCtD
Rufinamide—Dizziness—Methotrexate—breast cancer	2.92e-05	0.000208	CcSEcCtD
Rufinamide—Diarrhoea—Epirubicin—breast cancer	2.82e-05	0.000202	CcSEcCtD
Rufinamide—Hypersensitivity—Doxorubicin—breast cancer	2.81e-05	0.000201	CcSEcCtD
Rufinamide—Vomiting—Methotrexate—breast cancer	2.8e-05	0.0002	CcSEcCtD
Rufinamide—Rash—Methotrexate—breast cancer	2.78e-05	0.000199	CcSEcCtD
Rufinamide—Dermatitis—Methotrexate—breast cancer	2.78e-05	0.000198	CcSEcCtD
Rufinamide—Headache—Methotrexate—breast cancer	2.76e-05	0.000197	CcSEcCtD
Rufinamide—Asthenia—Doxorubicin—breast cancer	2.74e-05	0.000196	CcSEcCtD
Rufinamide—Dizziness—Epirubicin—breast cancer	2.73e-05	0.000195	CcSEcCtD
Rufinamide—Pruritus—Doxorubicin—breast cancer	2.7e-05	0.000193	CcSEcCtD
Rufinamide—Vomiting—Epirubicin—breast cancer	2.62e-05	0.000187	CcSEcCtD
Rufinamide—Nausea—Methotrexate—breast cancer	2.62e-05	0.000187	CcSEcCtD
Rufinamide—Diarrhoea—Doxorubicin—breast cancer	2.61e-05	0.000187	CcSEcCtD
Rufinamide—Rash—Epirubicin—breast cancer	2.6e-05	0.000186	CcSEcCtD
Rufinamide—Dermatitis—Epirubicin—breast cancer	2.6e-05	0.000186	CcSEcCtD
Rufinamide—Headache—Epirubicin—breast cancer	2.59e-05	0.000185	CcSEcCtD
Rufinamide—Dizziness—Doxorubicin—breast cancer	2.53e-05	0.00018	CcSEcCtD
Rufinamide—Nausea—Epirubicin—breast cancer	2.45e-05	0.000175	CcSEcCtD
Rufinamide—Vomiting—Doxorubicin—breast cancer	2.43e-05	0.000173	CcSEcCtD
Rufinamide—Rash—Doxorubicin—breast cancer	2.41e-05	0.000172	CcSEcCtD
Rufinamide—Dermatitis—Doxorubicin—breast cancer	2.41e-05	0.000172	CcSEcCtD
Rufinamide—Headache—Doxorubicin—breast cancer	2.39e-05	0.000171	CcSEcCtD
Rufinamide—Nausea—Doxorubicin—breast cancer	2.27e-05	0.000162	CcSEcCtD
Rufinamide—ALB—Metabolism—PPARGC1B—breast cancer	5.35e-06	5.07e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—HMOX1—breast cancer	5.32e-06	5.04e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—KRAS—breast cancer	5.3e-06	5.03e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	5.21e-06	4.94e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	5.21e-06	4.94e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NDUFS3—breast cancer	5.19e-06	4.92e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—ABCB1—breast cancer	5.1e-06	4.84e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—SRC—breast cancer	5.06e-06	4.8e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTA4—breast cancer	5.05e-06	4.79e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CA9—breast cancer	5.05e-06	4.79e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—GPX1—breast cancer	4.99e-06	4.73e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—HRAS—breast cancer	4.96e-06	4.71e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	4.94e-06	4.68e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—VEGFA—breast cancer	4.93e-06	4.67e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GPX2—breast cancer	4.92e-06	4.67e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTA2—breast cancer	4.92e-06	4.67e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CHST9—breast cancer	4.88e-06	4.63e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PIK3CA—breast cancer	4.87e-06	4.62e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—MMP1—breast cancer	4.87e-06	4.61e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GPX4—breast cancer	4.86e-06	4.61e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SULT1A1—breast cancer	4.86e-06	4.61e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—DPYD—breast cancer	4.79e-06	4.54e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—MED12—breast cancer	4.79e-06	4.54e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—CDK2—breast cancer	4.78e-06	4.53e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PLAU—breast cancer	4.78e-06	4.53e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTA1—breast cancer	4.75e-06	4.5e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—IDH1—breast cancer	4.75e-06	4.5e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—IL6—breast cancer	4.75e-06	4.5e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ALDOA—breast cancer	4.72e-06	4.47e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TP53—breast cancer	4.71e-06	4.47e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NAT2—breast cancer	4.7e-06	4.45e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—CAV1—breast cancer	4.66e-06	4.42e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—MAPK3—breast cancer	4.66e-06	4.42e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—COX11—breast cancer	4.63e-06	4.39e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NCOA3—breast cancer	4.58e-06	4.34e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SLC2A2—breast cancer	4.55e-06	4.31e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—TGFB1—breast cancer	4.52e-06	4.29e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—HRAS—breast cancer	4.51e-06	4.27e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ABCG2—breast cancer	4.46e-06	4.22e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CPT1A—breast cancer	4.46e-06	4.22e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—MTR—breast cancer	4.46e-06	4.22e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—FN1—breast cancer	4.44e-06	4.21e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—NOS2—breast cancer	4.39e-06	4.16e-05	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—AKT1—breast cancer	4.38e-06	4.15e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HPGDS—breast cancer	4.37e-06	4.14e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HBA1—breast cancer	4.34e-06	4.12e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IL6—breast cancer	4.32e-06	4.09e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CG—breast cancer	4.25e-06	4.03e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CAV1—breast cancer	4.25e-06	4.03e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ACHE—breast cancer	4.24e-06	4.02e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTT1—breast cancer	4.24e-06	4.02e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SHMT1—breast cancer	4.23e-06	4.01e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CDA—breast cancer	4.23e-06	4.01e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—EGF—breast cancer	4.2e-06	3.98e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—DPYD—breast cancer	4.12e-06	3.91e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MED12—breast cancer	4.12e-06	3.91e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLCO1B1—breast cancer	4.07e-06	3.86e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC2A5—breast cancer	4.07e-06	3.86e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ALDOA—breast cancer	4.05e-06	3.84e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP17A1—breast cancer	4.01e-06	3.8e-05	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—AKT1—breast cancer	3.98e-06	3.77e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTGS1—breast cancer	3.97e-06	3.77e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ENO1—breast cancer	3.97e-06	3.77e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NCOA3—breast cancer	3.94e-06	3.73e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—APRT—breast cancer	3.94e-06	3.73e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SLC2A2—breast cancer	3.91e-06	3.71e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP2D6—breast cancer	3.89e-06	3.69e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IGF1—breast cancer	3.89e-06	3.69e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—AKT2—breast cancer	3.89e-06	3.69e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	3.87e-06	3.67e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—PIK3CA—breast cancer	3.85e-06	3.65e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MTR—breast cancer	3.83e-06	3.63e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ABCG2—breast cancer	3.83e-06	3.63e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CPT1A—breast cancer	3.83e-06	3.63e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NCOA2—breast cancer	3.82e-06	3.62e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HPGDS—breast cancer	3.76e-06	3.56e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CD—breast cancer	3.74e-06	3.54e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HBA1—breast cancer	3.73e-06	3.54e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—FASN—breast cancer	3.71e-06	3.52e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ESRRA—breast cancer	3.7e-06	3.51e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ANGPTL4—breast cancer	3.7e-06	3.51e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SERPINE1—breast cancer	3.69e-06	3.5e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—BCHE—breast cancer	3.69e-06	3.5e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SLC5A5—breast cancer	3.65e-06	3.46e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTT1—breast cancer	3.64e-06	3.45e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ACHE—breast cancer	3.64e-06	3.45e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—NOS3—breast cancer	3.53e-06	3.34e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NQO1—breast cancer	3.52e-06	3.34e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SLC2A1—breast cancer	3.52e-06	3.34e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GPI—breast cancer	3.51e-06	3.33e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HADHB—breast cancer	3.51e-06	3.33e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP17A1—breast cancer	3.45e-06	3.27e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP3A4—breast cancer	3.43e-06	3.26e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTGS1—breast cancer	3.41e-06	3.24e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ENO1—breast cancer	3.41e-06	3.24e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.4e-06	3.22e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP1B1—breast cancer	3.38e-06	3.2e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP2D6—breast cancer	3.35e-06	3.17e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ALDH1A1—breast cancer	3.35e-06	3.17e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ALDH7A1—breast cancer	3.35e-06	3.17e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—RAF1—breast cancer	3.33e-06	3.16e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HSP90AA1—breast cancer	3.31e-06	3.14e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NCOA2—breast cancer	3.29e-06	3.11e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CB—breast cancer	3.26e-06	3.09e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NCOA1—breast cancer	3.22e-06	3.05e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—FHL2—breast cancer	3.21e-06	3.04e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—UMPS—breast cancer	3.21e-06	3.04e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NME1—breast cancer	3.21e-06	3.04e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PHGDH—breast cancer	3.21e-06	3.04e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ADSL—breast cancer	3.21e-06	3.04e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—FASN—breast cancer	3.19e-06	3.02e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP19A1—breast cancer	3.17e-06	3.01e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—STK11—breast cancer	3.17e-06	3.01e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—BCHE—breast cancer	3.17e-06	3.01e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HPSE—breast cancer	3.15e-06	2.98e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—BRIP1—breast cancer	3.15e-06	2.98e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—LDHB—breast cancer	3.15e-06	2.98e-05	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—AKT1—breast cancer	3.15e-06	2.98e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SLC5A5—breast cancer	3.13e-06	2.97e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NQO1—breast cancer	3.03e-06	2.87e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SLC2A1—breast cancer	3.03e-06	2.87e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IL2—breast cancer	2.99e-06	2.83e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ABCC1—breast cancer	2.98e-06	2.83e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTA3—breast cancer	2.98e-06	2.83e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HMMR—breast cancer	2.98e-06	2.83e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.96e-06	2.81e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP3A4—breast cancer	2.95e-06	2.8e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—COMT—breast cancer	2.95e-06	2.8e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTP1—breast cancer	2.94e-06	2.79e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.94e-06	2.78e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP1B1—breast cancer	2.9e-06	2.75e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HMOX1—breast cancer	2.9e-06	2.75e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ITPR1—breast cancer	2.89e-06	2.74e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PPARGC1B—breast cancer	2.89e-06	2.74e-05	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—RAF1—breast cancer	2.89e-06	2.74e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HSP90AA1—breast cancer	2.85e-06	2.7e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ABCB1—breast cancer	2.78e-06	2.64e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NCOA1—breast cancer	2.77e-06	2.62e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—TYMS—breast cancer	2.73e-06	2.59e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP19A1—breast cancer	2.73e-06	2.59e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—STK11—breast cancer	2.73e-06	2.59e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CA9—breast cancer	2.73e-06	2.59e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTA4—breast cancer	2.73e-06	2.59e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GSTM1—breast cancer	2.7e-06	2.56e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PLA2G4A—breast cancer	2.7e-06	2.56e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NCOR1—breast cancer	2.7e-06	2.56e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GPX2—breast cancer	2.66e-06	2.52e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTA2—breast cancer	2.66e-06	2.52e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GPX4—breast cancer	2.63e-06	2.49e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SULT1A1—breast cancer	2.63e-06	2.49e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SRC—breast cancer	2.61e-06	2.47e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GPX1—breast cancer	2.59e-06	2.45e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—IDH1—breast cancer	2.56e-06	2.43e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTA1—breast cancer	2.56e-06	2.43e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.56e-06	2.43e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP1A1—breast cancer	2.56e-06	2.43e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—VEGFA—breast cancer	2.54e-06	2.41e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ERCC2—breast cancer	2.54e-06	2.41e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—COMT—breast cancer	2.54e-06	2.41e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NAT2—breast cancer	2.54e-06	2.4e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTP1—breast cancer	2.52e-06	2.39e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HMOX1—breast cancer	2.49e-06	2.36e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ITPR1—breast cancer	2.48e-06	2.36e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—MAPK3—breast cancer	2.4e-06	2.28e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ABCB1—breast cancer	2.39e-06	2.27e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—MTHFR—breast cancer	2.39e-06	2.26e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—TYMS—breast cancer	2.35e-06	2.23e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TGFB1—breast cancer	2.33e-06	2.21e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PLA2G4A—breast cancer	2.32e-06	2.2e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NCOR1—breast cancer	2.32e-06	2.2e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GSTM1—breast cancer	2.32e-06	2.2e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—DPYD—breast cancer	2.22e-06	2.11e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MED12—breast cancer	2.22e-06	2.11e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GPX1—breast cancer	2.22e-06	2.11e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CAV1—breast cancer	2.2e-06	2.09e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP1A1—breast cancer	2.2e-06	2.09e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ALDOA—breast cancer	2.19e-06	2.08e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ERCC2—breast cancer	2.18e-06	2.07e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—KRAS—breast cancer	2.16e-06	2.05e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NCOA3—breast cancer	2.12e-06	2.01e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC2A2—breast cancer	2.11e-06	2e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CPT1A—breast cancer	2.07e-06	1.96e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MTR—breast cancer	2.07e-06	1.96e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ABCG2—breast cancer	2.07e-06	1.96e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MTHFR—breast cancer	2.05e-06	1.94e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HPGDS—breast cancer	2.03e-06	1.92e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HBA1—breast cancer	2.01e-06	1.91e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CG—breast cancer	2e-06	1.9e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PIK3CA—breast cancer	1.98e-06	1.88e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ACHE—breast cancer	1.97e-06	1.86e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTT1—breast cancer	1.97e-06	1.86e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—TP53—breast cancer	1.92e-06	1.82e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CAV1—breast cancer	1.89e-06	1.79e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP17A1—breast cancer	1.86e-06	1.76e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ENO1—breast cancer	1.84e-06	1.75e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTGS1—breast cancer	1.84e-06	1.75e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—HRAS—breast cancer	1.84e-06	1.74e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.81e-06	1.71e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP2D6—breast cancer	1.81e-06	1.71e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NCOA2—breast cancer	1.77e-06	1.68e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CD—breast cancer	1.76e-06	1.67e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ALB—breast cancer	1.74e-06	1.65e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CG—breast cancer	1.72e-06	1.63e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—FASN—breast cancer	1.72e-06	1.63e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—BCHE—breast cancer	1.71e-06	1.62e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC5A5—breast cancer	1.69e-06	1.6e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NOS3—breast cancer	1.66e-06	1.58e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC2A1—breast cancer	1.63e-06	1.55e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NQO1—breast cancer	1.63e-06	1.55e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—AKT1—breast cancer	1.62e-06	1.54e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP1B1—breast cancer	1.57e-06	1.49e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.54e-06	1.46e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CB—breast cancer	1.54e-06	1.46e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTGS2—breast cancer	1.52e-06	1.44e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CD—breast cancer	1.51e-06	1.44e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NCOA1—breast cancer	1.49e-06	1.42e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP19A1—breast cancer	1.47e-06	1.4e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—STK11—breast cancer	1.47e-06	1.4e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NOS3—breast cancer	1.43e-06	1.36e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—COMT—breast cancer	1.37e-06	1.3e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTP1—breast cancer	1.36e-06	1.29e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HMOX1—breast cancer	1.34e-06	1.27e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ITPR1—breast cancer	1.34e-06	1.27e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PTEN—breast cancer	1.33e-06	1.26e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CB—breast cancer	1.32e-06	1.25e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTGS2—breast cancer	1.31e-06	1.24e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ABCB1—breast cancer	1.29e-06	1.22e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TYMS—breast cancer	1.27e-06	1.2e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GSTM1—breast cancer	1.25e-06	1.19e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NCOR1—breast cancer	1.25e-06	1.19e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.25e-06	1.19e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GPX1—breast cancer	1.2e-06	1.14e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP1A1—breast cancer	1.19e-06	1.13e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ERCC2—breast cancer	1.18e-06	1.12e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PTEN—breast cancer	1.14e-06	1.08e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MTHFR—breast cancer	1.11e-06	1.05e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CAV1—breast cancer	1.02e-06	9.68e-06	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PIK3CA—breast cancer	9.36e-07	8.88e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CG—breast cancer	9.3e-07	8.82e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CD—breast cancer	8.18e-07	7.75e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ALB—breast cancer	8.07e-07	7.65e-06	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PIK3CA—breast cancer	8.05e-07	7.63e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NOS3—breast cancer	7.72e-07	7.32e-06	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AKT1—breast cancer	7.65e-07	7.25e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CB—breast cancer	7.13e-07	6.76e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTGS2—breast cancer	7.06e-07	6.69e-06	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AKT1—breast cancer	6.57e-07	6.23e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PTEN—breast cancer	6.16e-07	5.84e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PIK3CA—breast cancer	4.34e-07	4.12e-06	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AKT1—breast cancer	3.55e-07	3.36e-06	CbGpPWpGaD
